Katherine R. Schultz

3.2k total citations
8 papers, 511 citations indexed

About

Katherine R. Schultz is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Katherine R. Schultz has authored 8 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Katherine R. Schultz's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (5 papers) and Cancer therapeutics and mechanisms (1 paper). Katherine R. Schultz is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (5 papers) and Cancer therapeutics and mechanisms (1 paper). Katherine R. Schultz collaborates with scholars based in United States, Australia and Japan. Katherine R. Schultz's co-authors include Alice T. Shaw, Justin F. Gainor, Luc Friboulet, Beow Y. Yeap, Ibiayi Dagogo‐Jack, Satoshi Yoda, Leila Dardaei, Jeffrey A. Engelman, Aaron N. Hata and Zofia Piotrowska and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and European Journal of Cancer.

In The Last Decade

Katherine R. Schultz

7 papers receiving 506 citations

Peers

Katherine R. Schultz
Lorin A. Ferris United States
Amanda C. Pawlak United States
Jieling Miao United States
Philip Tracy United States
Katherine R. Schultz
Citations per year, relative to Katherine R. Schultz Katherine R. Schultz (= 1×) peers Vlatka Smoljanović

Countries citing papers authored by Katherine R. Schultz

Since Specialization
Citations

This map shows the geographic impact of Katherine R. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine R. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine R. Schultz more than expected).

Fields of papers citing papers by Katherine R. Schultz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine R. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine R. Schultz. The network helps show where Katherine R. Schultz may publish in the future.

Co-authorship network of co-authors of Katherine R. Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine R. Schultz. A scholar is included among the top collaborators of Katherine R. Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine R. Schultz. Katherine R. Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gainor, Justin F., Diane Tseng, Satoshi Yoda, et al.. (2017). Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non–Small-Cell Lung Cancer. JCO Precision Oncology. 2017(1). 1–13. 200 indexed citations
2.
Dagogo‐Jack, Ibiayi, Justin F. Gainor, Rebecca L. Porter, et al.. (2016). Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping. Journal of Thoracic Oncology. 11(9). 1522–1528. 17 indexed citations
3.
Schultz, Katherine R.. (2016). Pneumologie – Lehrbuch für Atmungstherapeuten. Pneumologie. 70(6). 404–404.
4.
Gainor, Justin F., Luc Friboulet, Satoshi Yoda, et al.. (2016). Frequency and spectrum of ROS1 resistance mutations in ROS1-positive lung cancer patients progressing on crizotinib.. Journal of Clinical Oncology. 34(15_suppl). 9072–9072. 13 indexed citations
5.
Gainor, Justin F., Leila Dardaei, Satoshi Yoda, et al.. (2016). Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer. European Journal of Cancer. 69. S138–S138. 119 indexed citations
6.
Gainor, Justin F., Daniel Shao-Weng Tan, Benjamin Solomon, et al.. (2015). Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib. Clinical Cancer Research. 21(12). 2745–2752. 135 indexed citations
7.
Gainor, Justin F., Lecia V. Sequist, Alice T. Shaw, et al.. (2015). Clinical correlation and frequency of programmed death ligand-1 (PD-L1) expression in EGFR-mutant and ALK-rearranged non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 33(15_suppl). 8012–8012. 22 indexed citations
8.
Gainor, Justin F., Luc Friboulet, Ryohei Katayama, et al.. (2014). Evolution of resistance in ALK-positive patients treated with ALK tyrosine kinase inhibitors (TKIs).. Journal of Clinical Oncology. 32(15_suppl). 8031–8031. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026